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Abstract: W hile the negative influence of environm ental pollution on the respiratory system  is w ell 
established, especially for people w ith bronchial hyper-reactivity, the im pact of particulate m atter on 
quality of life in asthm a patients is not w ell understood. Three hundred adult asthm a patients w ere 
recruited for a study; for each patient, the daily concentrations of particulate m atter of 2.5 pm or less 
in diam eter (PM 2.5 ) w ere recorded from  air quality m onitoring stations. The study w as conducted 
over tw o w eeks. A fter tw o w eeks, the patients filled out the A sthm a Q uality  of Life Q uestionnaire 
(AQLQ), evaluating the quality of their lives throughout the monitored period. Patients exposed to a 
higher concentration of PM 2.5 had significantly lower AQLQ scores. Every 10 pg/m3 of an increase in 
the concentration of PM 2.5 resulted in a decrease of the A Q LQ  score by  0.16. A ll dom ains of quality 
of life (sym ptom s, activity lim itations, em otional functioning, and environmental stim uli) assessed in 
the questionnaire were negatively affected by PM 2.5 . These findings provide an im portant argument 
in favor of educating physicians and patients and raising aw areness about the detrim ental health 
effects of air pollution. Im proving the quality  of life of people w ith  asthm a requires an im m ediate 
and substantial reduction of air pollution.
Keyw ords: environm ental health; PM 2.5 ; quality of life; AQLQ; asthm a
1. Introduction
Bronchial asthm a is one of the m ost frequently occurring chronic diseases [1] . Like every chronic 
disease, it poses a major problem not only in m edical terms but also in social and econom ic terms [2- 5 ]. 
As a long-term , incurable disease, it is a source of hardship and limitations for many patients pursuing 
their everyday activities, negatively im pacting the quality of their lives.
The negative influence of particulate m atter (PM ) on the respiratory system  has been  know n 
for a long tim e, especially  in the case of patients w ith  bronchial hyper-reactivity [6,7]. H ow ever, the 
evaluation of the im pact of particulate m atter on the quality of life of patients w ith bronchial asthm a 
has not yet been w idely analyzed. To the best of our knowledge, only limited evidence exists to suggest 
that fine particles m easuring less than 10 pm (PM 10) has an im pact on the quality  of life of patients 
w ith  bronchial asthm a [8 ], w ith  no conclusive confirm ation of the detrim ental connection betw een 
the quality of life and the concentration of P M i0. N o studies w ere conducted concerning particulate 
m atter of 2.5 pm or less in diam eter (PM 2.5).
PM 2.5 (particles w hich pass through a size-selective inlet w ith  a 50%  efficiency cut-off at 2.5 pm 
aerodynam ic diam eter) have been classified by International Organization for Standardization as the 
"h ig h -risk " respirable fraction [9 ]. PM 2.5 , also know n as respirable dust, is an exceptionally  harm ful 
fraction because it penetrates the sm allest bronchioles and the alveoli. Therefore, it m ay interfere
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w ith  gas exchange inside the lungs and trigger or exacerbate respiratory diseases. M oreover, som e 
fraction of inhaled PM 2.5 (most likely the fraction of particles under 0 .1  micrometer) may be capable to 
translocate into blood vessels and then spread w ith the blood to various tissues and organs [1 0 ].
According to W HO, the m axim um  24 h average concentration of PM 2.5 should not exceed 25 gg/m3. 
A t the sam e tim e, w hile considering PM 2.5 as "th e  m ost harm ful am ong all atm ospheric pollutants", 
W HO states there is no safe level, below w hich we can be sure of the lack of negative effects for hum an 
health [1 1 ].
In  studies conducted to date, researchers evaluated the im pact o f air pollutants m ainly on the 
aggravation of sym ptom s of asthm a [10,12,13]. H ow ever, an evaluation of the relationship betw een 
the environment and the quality of life of patients suffering from bronchial asthma has not yet been the 
subject of a sufficient num ber of studies. Results of such studies w ould be im portant in planning and 
im plementing preventive measures taken in the area of public health, and would lead to the well-being 
of patients w ith bronchial asthm a. The aim of our study w as the evaluation of the im pact of PM 2.5 air 
pollution on the self-assessed quality of life of patients w ith bronchial asthm a.
2. M aterials and M ethods
Patients w ith  bronchial asthm a (n =  349) w ho w ere treated in tw o allergy treatm ent clinics in 
Krakow , Poland w ere recruited for the study betw een June 2013 and M ay 2015. The d iagnosis of 
asthm a w as confirm ed by a physician (allergy specialist) according to the current guidelines [14]. 
Participants of the study were adult patients (>18  years old) w ith partially controlled asthma and were 
inhabitants o f Krakow , in Poland. They declared that they w ould not leave the city  throughout the 
14 days of observation. Partly-controlled asthma m eans that patient had been experiencing one or two 
of the following features of asthma in the past four weeks: daytime sym ptom s more than twice a week, 
n ight w aking due to asthm a, rescue m edication needed  for sym ptom  relief m ore than tw ice a w eek, 
activity lim itation due to asthm a [14].
D uring the first visit, the physician conducted the interview and recorded inform ation about the 
date of birth, place of residence, education, em ploym ent, sm oking, having pets, and types of asthm a 
treatm ent. D uring the first visit, the patients also signed the inform ed consent for participation in the 
study and received a journal for recording the num ber of hours spent outside and the nam e of streets 
that they used for w alking or travel each day. Each patient recorded this inform ation every day for 
two weeks.
For each patient, we recorded the daily concentrations of PM 2.5 for each day of observation from all 
available air quality m onitoring stations of the Voivodeship Inspectorate of Environm ental Protection 
in Krakow. Subsequently, each patient w as assigned to the station closest to their declared outdoor 
place of stay, to estimate exposure to PM 2.5 during the study. During the second visit (after 14 days) the 
patients' quality of life w as evaluated using the Standardised A sthm a Q uality of Life Q uestionnaire 
(AQLQ) for adults [15- 17], which has been com m only used for m easuring the asthm a-specific quality 
of life [16,18]. The patients filled out the A Q LQ , consisting of 32 questions (concerning the last 
14  days). Q uestions w ere grouped into four dom ains: sym ptom s (12 questions), activity lim itations 
(1 1  questions), em otional functioning (five questions), and environm ental stim uli (four questions).
The patients m arked their answ ers to each question on a seven-degree L ikert scale, on w hich 7 
m eant "no lim itations", and 1 m eant "total lim itations" in performing particular activities. The overall 
score of the AQ LQ  total w as the average of all 32 answ ers, and the score for a particular dom ain w as 
the average value for the questions w ithin this domain.
For analysis, w e used the data from  300 patients aged 2 0 -8 0  years old (m ean 53, standard 
deviation/SD /15.3): 145 w om en (48.3% ) and 155 m en (51.7% ). Forty-nine patients (14% — 23 w om en 
and 26 men, aged 20-76 years old; mean 51, SD 13.3) were excluded due to leaving the city throughout 
observation or not filling out/losing the journal of observations. The study w as conducted w ith  the 
approval of the Com m ittee of Bioethics of the Jagiellonian U niversity (num ber KBET/167/B/2012).
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D ata w ere presented as m eans w ith  standard deviations (SD) or the frequency w ith  percentage 
d istribution, respectively  to its m easurem ent scale. Tw o-w eek m ean PM 2 5  concentrations w ere 
additionally  characterized by  their quartile distribution. PM 2 5  concentration w as analyzed both as 
a continuous variable and as a categorical variable, according to its quartile distribution. Potential 
confounders of PM 2.5 exposure and AQ LQ, such as gender, education, active sm oking, em ploym ent 
status, and having pets at hom e, w ere controlled in  analyses. A ssociations betw een these nom inal 
variables and PM 2.5 categories w ere verified using a chi-square test or the exact Fisher test w hen 
appropriate. Differences in the age of patients exposed to different concentrations of PM 2.5 categories 
(different quartiles) w ere tested using one-w ay AN OVA (equality o f variances has been  verified 
w ith  L evene's test and norm al d istribution in subgroups w ith  the K ołm ogorow -Sm irnow  test). 
The nonparam etric trend in AQ LQ  values across PM 2.5 categories w as checked.
The potential im pact of airborne PM 2.5 on the quality of life of asthm a patients (AQLQ total and 
its four dom ains) w as estim ated w ith  linear regression m odels using the tw o-w eek m ean of P M 2.5 
concentrations both as a categorical variable (according to quartile distribution and by the value 
of 25 pg/m 3— the 24 h threshold suggested by W H O , w hich  w e used since there is no tw o-w eek 
guideline value) and as a continuous variable w ith a unit of 1 0  pg/m3, both adjusted to age (in years), 
gender, and university education (yes versus no) smoking (yes versus no) and season of measurement 
(cold: O ctober to April, versus warm: M ay-Septem ber). Am ong the variables considered as potential 
confounders, only age and university education were significantly associated with AQLQ total and its 
dom ains in univariate analysis. Gender, sm oking, and season of m easurem ent w ere a priori added 
to m odels.
The A Q LQ  total w as classified into three categories: good quality of life (score: 6 -7 ), reduced 
quality of life (score: 4-5), and poor quality of life (score: 1-3), ordered from good as "1 "  to poor as "3 ". 
PM 2.5 exposure level (both as a categorical and continuous variable) w as used to assess its im pact on 
poor asthma quality of life using ordered logistic regression m odels adjusted to age, age2, gender, and 
university education. The same analyses were conducted for all four AQ LQ  domains, as four separate 
tests. The proportional odds assumption w as verified using the Brant test. The term age2 was added as 
age had not com plied w ith the proportional odds assum ption. The ordered logistic regression models 
w ere not adjusted for sm oking as it did not affect the risk of poorer asthm a life quality. Besides, only 
31 (10% ) patients w ere sm okers. These patients w ere attem pting to quit sm oking and they reported 
sm oking no m ore than betw een one to three cigarettes per day at the tim e of observation. A ll tests 
were two-tailed, and significance w as set at p <  0.05. All analyses were performed using STATA/IC 13.1 
(StataCorp LP, C ollege Station, TX, USA).
3. Results
PM 2.5 exposure (m ean in  a tw o-w eek period) averaged 45.1 pg/m 3 (m edian 46; range: 
9 .6-90 .1  pg/m 3) and only 75 (25% ) patients w ere exposed to values low er or equal to 25 pg/m 3, 
the 24 h threshold recom m ended by W H O . PM 2.5 m easurem ents w ere equally  d istributed across 
seasons. There w ere no statistically significant differences betw een patients in  the num ber of hours 
spent outdoors. In general, all declared that they spend 2 -3  h a day outdoors, on average.
Groups of patients w ith different average PM 2.5 exposure levels (classified by  quartiles of PM 2.5 ) 
did n ot differ significantly in gender, education level (university versus low er), em ploym ent status, 
or keeping pets at hom e. N evertheless, patients exposed to higher levels of PM 2.5 w ere older and 
the studied subgroups w ere significantly different according to active sm oking prevalence (Table 1). 
The m ean asthm a quality  of life (A Q LQ  total) in  the studied group w as 5.0 (range: 2 -7 ). D eclining 
trends in total and specific domains of asthma quality of life were observed across increasing levels of 
airborne PM 2.5 exposure (Table 1 ).
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Table 1. Characteristics of the study group: all participants and participants divided in four groups 
based on quartiles of exposure to PM2.5 levels.



















women 145 (48.3%) 36 (48.0%) 30 (40.0%) 40 (53.3%) 39 (52.0%) n0.356men 155 (51.7%) 39 (52.0%) 45 (60.0%) 35 (46.7%) 36 (48.0%)
age (years) 53 ± 15.3 49.8 ± 15.7 51.3 ± 15.5 52.1 ± 13.3 59.0 ± 15.3 0.001
university education 127 (42.3%) 39 (52%) 35 (46.7%) 29 (38.7%) 24 (32%) 0.068
active smoker 31 (10.3%) 1 (1.3%) 11 (14.7%) 16 (21.3%) 3 (4.0%) <0.001
current employment
student 11 (3.7%) 3 (4.0%) 4 (5.3%) 3 (4.1%) 1 (1.3%)
employed 172 (57.5%) 47 (62.7%) 48 (64.0%) 43 (58.1%) 34 (45.3%) n 19 a 0. 24unemployed 27 (9.0%) 7 (9.3%) 5 (6.7%) 9 (12.2%) 6 (8.0%)
retired 89 (29.8%) 18 (24.0%) 18 (24.0%) 19 (25.7%) 34 (45.3%)
missing 1
keeping pets at home 133 (43.3%) 34 (45.3%) 33 (75%) 28 (37.3%) 38 (50.7%) 0.433
quality of life in asthma
AQLQ * total 5.0 ± 1.29 5.6 ± 1.11 5.1 ± 1.14 4.8 ± 1.15 4.4 ± 1.43 <0.001
AQLQ symptoms 5.2 ± 1.34 5.7 ± 1.23 5.3 ± 1.13 5.1 ± 1.28 4.6 ± 1.48 <0.001
AQLQ activity limitation 4.9 ± 1.37 5.7 ± 1.14 5.0 ± 1.25 4.7 ± 1.18 4.3 ± 1.51 <0.001
AQLQ emotional function 5.0 ± 1.53 5.6 ± 1.21 5.1 ± 1.36 4.9 ± 1.51 4.4 ± 1.78 <0.001
AQLQ environmental 4.6 ± 1.33 5.4 ± 1.35 4.6 ± 1.22 4.3 ± 1.22 4.2 ± 1.2 <0.001stimuli
* Asthma Quality of Life Questionnaire score.
Table 2  show s the effect of categorized PM 2.5 exposure on asthm a quality  of life, adjusted to 
potential confounders. First, w e com pared patients exposed to the PM 2.5 values above 25 pg/m3 with 
those exposed to lower pollution levels (<25 pg/m3). A reduction of 0.6 in the AQLQ total was observed 
in those exposed to the higher levels com pared to those w ith  PM 2.5 exposure < 2 5  pg/m 3, w hile the 
deficit in  specific dom ains w as statistically significant in the case of A Q LQ  sym ptom s and A Q LQ  
environm ental stim uli. W hen quartiles of PM 2.5 exposure w ere com pared, after adjustm ents for the 
confounders, the effect of exposure becam e significant in all domains (Table 2). The observed effect of 
the increased level of exposure w as associated w ith reduced values in the AQLQ total in all higher-level 
quartiles of exposure, in com parison to low-level quartiles. A sim ilar decrease was observed in AQLQ 
sym ptom s and A Q LQ  environm ental stim uli dom ains. In A Q LQ  activity  lim itations and em otional 
functioning, quality  of life differed significantly only betw een the extrem ely high-level quartile of 
exposure and low -level quartile . Predicted m argins of A Q LQ  and its dom ains according to P M 2.5 
levels, categorized by  quartile distribution, and adjusted to age, gender, active sm oking, university 
education, and season of m easurem ent, are presented in Figure 1.
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Table 2. Impact of categorized concentration of PM2.5 on asthma quality of life (AQLQ) and the risk of 
poor asthma quality of life, adjusted to potential confounders.
C oncentration  of P M 2.5 
C ategorized  A ccord in g  to 24 h 
T h reshold  
(> 25 pg/m 3, n =  225 versu s < 
25 pg/m 3, n =  75) and  
A cco rd in g  to the Q u artiles
A sth m a Q u ality  of L ife  on 
O rigin al S cale
C ategorized  A sth m a Q u ality  of L ife  
(O rdered from  G ood as " 1 "  to Poor 
as "3 " )
B * 95%  CI fo r B p a O R  95%  CI ** fo r O R p b
AQLQ total
>25 pg/m3 versus < 25 pg/m3 -0.56 -0.98; -0.13 0.011 5.12 2.72; 9.63 < 0.001
high versus low -0.45 - 0 .88 ; - 0.01 0.044 2 .68 1.28; 5.60 0.009
very high versus low -0.74 -1.24; -0.24 0.004 7.34 3.50; 15.42 < 0.001
extremely high versus low - 0.86 -1.37; -0.34 < 0.001 7.17 3.39; 15.20 < 0.001
AQLQ symptoms
>25 pg/m3 versus < 25 pg/m3 -0.63 -1.08; -0.17 0.007 3.51 1.82; 6.77 0.001
high versus low -0.50 -0.97; -0.05 0.029 2.24 1.04; 4.84 0.039
very high versus low -0.79 -1.32; -0.26 0.003 3.59 1.67; 7.72 0.001
extremely high versus low -0.99 -1.53; -0.44 < 0.001 5.30 2.48; 11.31 < 0.001
AQLQ activity limitation
>25 pg/m3 versus < 25 pg/m3 -0.41 -0.86; 0.04 0.074 5.74 3.07; 10.73 < 0.001
high versus low -0.31 -0.77; 0.14 0.177 3.10 1.49; 6.43 0.002
very high versus low -0.51 -1.03; 0.01 0.055 8.05 3.84; 16.90 < 0.001
extremely high versus low -0.76 -1.30; -0.22 0.006 8.01 3.81; 16.85 < 0.001
AQLQ emotional function
>25 pg/m3 versus < 25 pg/m3 -0.38 -0.91; 0.14 0.155 2.30 1.30; 4.07 0.004
high versus low -0.35 -0.89; 0.19 0.206 1.94 0.98; 3.84 0.055
very high versus low -0.34 -0.96; 0.28 0.279 2.72 1.36; 5.43 0.004
extremely high versus low -0.64 -1.28; 0.001 0.050 2.33 1.17; 4.62 0.016
AQLQ environmental stimuli
>25 pg/m3 versus < 25 pg/m3 -0.78 -1.25; -0.30 < 0.001 4.78 2.72; 8.38 < 0.001
high versus low -0.67 -1.16; -0.19 0.007 3.24 1.67; 6.26 < 0.001
very high versus low - 1.02 -1.58; -0.46 < 0.001 6.06 3.04; 12.09 < 0.001
extremely high versus low -0.95 -1.53; -0.37 0.001 6.08 3.02; 12.24 < 0.001
* B—standardized coefficient (beta); ** CI— confidence intervals (a) adjusted to age, gender, active smoking, 
university education and season of measurement; (b) adjusted to age, age2, gender, and university education.
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Figure 1. Margins with 95% confidence intervals of (a) the Asthma Quality of Life Questionnaire (AQLQ) 
total, (b) AQLQ symptoms, (c) activity limitations, (d) emotional functioning, and (e) environmental 
stimuli and its domains according to PM2.5 levels (linear prediction adjusted to age, gender, active 
smoking, university ed ucation, and season of measurement).
To assess the effects of P M 2 5 exposure on the risk of poorer outcom es in  asthm a quality  of life 
(total and at specific dom ains) m ultivariable ordinal logistic regression m odels w ere applied. It w as 
observed that high lev els of PM 2.5 exposure w ere associated ovith over two-Oold higher risk of poorer 
outcomes in AQLQ total (OR =  2 .68 ,95%  CI =  n.28; 5.60, p  =  0.009), w hile tho very high and extremely 
high exposure w ere associated w ith over seven-fold higher ((OR =  7.34s 95% CI =  3.50; 15.42, p <  0.001 
and O R  =  7.17, 95% C I =  3.39; 15.20, p  <  0.001, respectively), com pared to the low  levels of P M 4.5 
exposure. Sim ilar results w ere seen in pedicu lar dom ains. Tine risk of poorer quality of life in AQLQ 
sym ptom s readied values from 2 .2  tim es higher for high levels; of PM 2.5 to 5.3 for the extxemely high 
levels com pared to the low levels. H igher risk of poor outcom es in AQLQ environm ental stim uli was 
3.2 tim es higher hor high levels of exposure and 6  tim es higher for very and extrem ely high exposure 
com pared to the exposure to lxw  levels (Table 2 ).
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Tire effect of a continuously expressed level of PM 2.5 exposure on asthm a quality of life, adjusted 
to poeential confounders, is show n in  Table 3. The risk of poorer asthm a quality of life increased 
w ith higher level oe PM 2.5 exposure. A 10 pgem3 increase in PM 2.5 w as significantly associated w ith a 
46%o higher risk of pooras total asthm a quality o f life (O R =3 1.4(3, 95°% CI =1 .29 ; 1.66, p <  g.001) after 
adjus tm ent for age, gender, and university education. Sim ilar results w ere observed in each dom ain, 
w hore a 10 pg/m 3 increase in  PM 2.5 increased the aisk of poorer outcom es in all A Q LQ  dom ains, 
from  21%e iri A Q LQ  em otional functioning to 46%  in  A Q LQ  activity  lim itation (Table 3 ). Predicted 
probabilities of "p o o r" asthm a quality  of life according to PM 2.5 exposure in  all A Q LQ  dom ains are 
presented in Figure 2 .
Table 3. Impact of mean 14-day concentration of PM2.5 (increasing unit: 10 pg/m3) on asthma quality 
of life and the risk of poor asthma quality of life, adjusted to potential confounders.
PM2.5 Concentration Asthma Quality of Life on Original Scale
Categorized Asthma Quality of 
Life (Ordered from Good as "1" to 
Poor as "3")
B * 95% CI for B p a OR 95% CI for OR p b
14-day concentrations of PM2.5
AQLQ total 
-0.16 -0.24; -0 .07  <0.001 1.46 1.29; 1.66 < 0.001
14-day concentrations ol PM2.5
AQLQ symptoms 
-0.18 -0.27; -0 .09 <0.001 1.37 1.20; 1.55 < 0.001
14-day concentrations ol PM2.5
AQLQ activity lfmitation 
-0.14 -0.23; -0 .06 <0.001 1.46 1.29; 1.66 < 0.001
14-day concentrations ol PM2.5
AQLQ emotional fraction 
-0.15 -0.26; -0 .05 0.004 1.21 0.91; 1.20 0 .002
14-day concentrations of PM2./
AQLQ environmental ftimuli 
-0.14 -0.24; -0 .05 0.003 1.40 1.24i 1.58 < 0.001
* B—standardized coefficient (beta); (a) adjusted to age, gender, active smoking, university education, and season of 
measurement; (b) adjusted to age, age2, gender, and university education.
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Figure 2. Predicted probabilities of "poor" asthma quality of life (total and for specific domains) 
according to PM2.5 levels.
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4. D iscussion
In  our study, w e com pared the quality  o f life of patients exposed to various concentrations of 
environm ental PM 2.5 and w e observed that increased levels of PM 2.5 w ere related to low er asthm a 
quality of life. Total quality of life and all of its four domains (symptoms, activity limitations, emotional 
functioning, and environmental stimuli) assessed in the study were significantly reduced as a result of 
air pollution.
It seems that in evaluating the quality of life it is not just the fact of exceeding the W H O  guideline 
value of PM 2.5 exposure that is significant, but also the degree of exceeding the W H O guideline value as 
well— in situations where the W HO guideline value w as exceeded multiple times all domains of quality 
of life show lower scores. The m ost easily influenced factors of quality of life were symptoms of asthma 
and environm ental stim uli, w hich decrease w ith every case of exceeding the W H O  guideline value.
The influence of particulate pollutants, including the PM 2.5 fraction, on different aspects of 
health  has been addressed by  m any studies. The negative im pact of PM 2 5  on the respiratory system  
is very w ell docum ented by studies, show ing connections betw een concentrations of P M 2.5 and 
longevity [1 9 ,2 0 ] , frequency of lung carcinom a [2 1 ,2 2 ] , the incidence of respiratory diseases, and 
exacerbations of such diseases and cardiovascular diseases [23- 25].
M athem atical m odels estim ated that exposure to PM 2.5 has decreased average longevity by 
8 .6  m onths in  Estonia [19], and other studies docum ented an increase of longevity  by as m uch as 
0.35 years for every 10 pg/m 3 of reduction in the concentration of this fraction  of particles [20]. 
Long-term  exposure to particulate matter PM 2.5 leads to increased m ortality due to lung cancer [26,27] 
and an  increased incidence of circulatory diseases [28] . In the U nited States of A m erica, overall 
m ortality and m orbidity for cardiovascular diseases and pulm onary diseases (including lung cancer) 
increased by 4% , 6 %, and 8 % respectively  for every additional 10 pg/m 3 of exposure to PM 2 5 after 
excluding other risk factors [29]. It has also been  docum ented that the 15-27%  increase in m ortality  
due to lung cancer w as connected with the increase in the concentration of PM 2.5 by 10 pg/m3, and the 
risk w as even higher for patients w ith  chronic lung diseases [30]. The results of 11 cohort studies in 
Europe have shown that the hazard ratio for lung adenocarcinoma w as 1.55 for every 5 pg/m3 increase 
in PM 2 5 [21], and in six regions of Japan, studies have show n a relationship betw een exposure to 
increased concentrations of PM 2.5 and the incidence of lung cancer [2 2 ].
The negative im pact of PM 2 5 on  the respiratory system  is confirm ed by  a system atic review  of 
epidemiological studies [31]. Other analyses have shown that the increase of PM 2.5 by 10 pg/m3 caused 
a 2.07%  increase in the incidence of respiratory diseases and an 8 % increase in  the hospitalization 
rate [32,33]. Among the residents of the Chinese canton Guangzhou, a 12.07% increase in the incidence 
of respiratory diseases for every 100 pg/m 3 of increase in PM 2.5 w as described [34].
Air pollution causes oxidative stress, leading to inflam m atory responses of respiratory tracts and 
bronchial hypersensitivity— typical features of asthma [35]. Moreover, it has been proven that long-term 
exposure to pollutants from m otor vehicle exhaust is related to the developm ent of asthm a [10,36,37]. 
Sudden increases in air pollution cause the aggravation of sym ptom s of asthma and an increase in the 
num ber of hospital admissions in both children and adults [10,12,13]. Studies on the influence of PM 2.5 
have dem onstrated a relationship betw een the increased concentration of this fraction of particulate 
m atter and the incidence of new cases of bronchial asthm a [38], as w ell as the deterioration of control, 
w ith necessary m edical intervention in hospital em ergency w ards [23,24,39,40].
H ow ever, previous studies did n ot investigate the influences of concentrations of PM 2 5 on the 
quality of life of asthm a patients. O n the one hand, it may seem  that w idely available d iagnostic 
m ethods are sufficient to evaluate the control of bronchial asthm a, even though they do not reflect a 
complete evaluation of the patient's health, which is influenced not only by physical problems but also 
by psychological and social issues. That is why, on the other hand, the evaluation of the quality of life, 
especially in chronic d iseases, seem s to be im portant, though not alw ays appreciated . It should be 
em phasized that quality of life is a crucial elem ent of the contem porary understanding of health [41]. 
Thus, it is im portant to evaluate various factors that m ay im pact the quality of life. Among such factors
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are sym ptom s of illnesses, lim itations of activity (physical, social, professional, em otional), and sleep 
disorders, but also environm ental hazards, including particulate pollutants.
Anecdotal evidence suggests that medical doctors specializing in asthma and allergy often register 
a correlation betw een a patient's w orse state of being and periods of increased air pollution, bu t it 
is d ifficult to determ ine w hether this is a result of publicity  by  a m edia aw areness of air pollution, 
or if the patients' quality of life is actually decreased at that time. In our study, w e recruited patients 
that w ere under the regular care of an allergy clinic. It w as a fairly  hom ogenous group, that is, 
patients w ith partially controlled asthma, well educated about asthma (e.g., recognizing and controlling 
sym ptom s of the disease, w ith  know ledge about a type and use of m edication) and system atically 
taking their m edication.
O ur study had some limitations. We assessed individual exposure based on PM 2.5 recorded for the 
city, w hile more precise m ethods of evaluating PM 2.5 exposure are potentially available. For exam ple, 
patients could carry m obile dust m onitors. However, technical and financial lim itations related to the 
equipm ent and p atients' com pliance w ould m ake such a study expensive and d ifficult to conduct, 
especially on a large group of participants. M ore sophisticated m odels could be used to assess personal 
exposure [42- 44]. A ir quality  is changing over space and tim e and people travel and spend tim e at 
various locations. Therefore, in future studies m ore detailed data should be used, for exam ple, the 
duration of time spent outside in each location and mode and routes of travel would make it easier to 
capture the full range of personal exposure.
Moreover, in our models, we used two-week mean values of PM 2.5 concentration. The aggravation 
of sym ptom s of asthm a is often caused by  sudden increases in  air pollution. Therefore, the peak 
m easurem ents seem  m ore relevant for exacerbations of asthm a than the 14 days average. How ever, 
it is w orth  em phasizing that the quality  o f life of patients w ith  bronchial asthm a does not solely 
depend on acute asthma attacks. Since AQLQ contains questions concerning the last 14 days, we used 
tw o-week m ean values of PM 2.5 concentration as an exposure indicator metric. It is also w orth noting 
that since there is no guideline value for a tw o-w eek average PM 2.5 concentration, w e used the W H O  
guideline value, w hich  is a 24 h average value as a lim it value. Future studies should also consider 
other pollutants, since there is grow ing evidence suggesting the synergistic effect of m ulti-pollutant 
exposures [45,46]. Finally, people spend m ost of their tim e indoors. For exam ple, our participants 
spent only 2 -3  h a day outdoors, on average. For these reasons, indoor sources of air pollution should 
be taken into account. How ever, w e have recently show n that outdoor PM 2 5 concentration strongly 
predicts indoor concentration [47] .
D espite all these lim itations, w e have been able to show  that even relatively sim ple inform ation 
about PM 2.5 concentration, w hich is easily accessible for citizens, from  air quality m onitoring stations 
m ay predict the quality of life of asthm a patients. Being aware that there is no m inim um  level of safe 
exposure to PM 2.5 , physicians taking care of asthma patients should pay special attention to the course 
of illness and control of patients w ith bronchial asthma to air pollution, especially in places where high 
concentrations of PM 2.5 occur during m any days over the year.
5. Conclusions
Exposure to increased values of PM 2.5 im pacts the quality of life am ong people w ith exceptional 
predispositions, such as bronchial asthma patients, which serves as an im portant argument in favor of 
educational activities, especially concerning public health, and raising awareness of the im portance of 
the issue of air pollution.
The deterioration in the quality of life of patients w ith asthma control and m edication suggests the 
need for special control throughout the illness during periods of exposure to increased concentrations 
of PM 2.5, and it is a fact that should be rem em bered both by doctors and patients them selves.
Besides taking measures for the im provem ent in the quality of air, it seems equally im portant to raise 
awareness about sources of air pollution, factors influencing concentration values, and possible methods 
of reducing ambient and personal exposure, especially among patients w ith bronchial hyper-reactivity.
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The substantial reduction of air pollution should be the first and im mediate request. Appropriate 
actions should be taken by governm ental organizations, local authorities, and inhabitants. Education 
and raising aw areness about the health  risk of h igh-level PM 2.5 should be a priority  for public 
health experts.
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